Method for estimating high sdLDL-C by measuring triglyceride and apolipoprotein B levels.

Area of Science:

• Cardiovascular Medicine
• Lipid Metabolism
• Clinical Chemistry

Background:

• Direct measurement of small dense low-density lipoprotein cholesterol (sdLDL-C) is not standard clinical practice.
• A simpler method, the "LDL window," is proposed to estimate high sdLDL-C levels using conventional assays.

Purpose of the Study:

• To develop and validate a simpler method, the "LDL window," for estimating high sdLDL-C levels.
• To assess the utility of the "LDL window" in identifying patients at high risk for coronary artery disease (CAD).

Main Methods:

• Analysis of previous studies (2006-2008) involving healthy subjects, type 2 diabetes, and CAD patients.
• Utilized apolipoprotein B (apoB) for LDL particle number estimation (cutoff: 110 mg/dL) and triglycerides (TGs) for LDL particle size estimation (cutoff: 150 mg/dL).
• An "alternative LDL window" used non-high-density lipoprotein cholesterol (non-HDL-C) (cutoff: 170 mg/dL) and TG.

Main Results:

• The hyper-triglyceridemia/hyper-apolipoprotein B (hyper-TG/hyper-apoB) group in the "LDL window" comprised over 90% of subjects with high sdLDL-C (Q4).
• sdLDL-C levels were significantly higher (50%) in the hyper-TG/hyper-apoB group among patients with diabetes and CAD compared to controls.
• Similar findings were observed using the "alternative LDL window."

Conclusions:

• The proposed "LDL window" method effectively identifies individuals with high sdLDL-C.
• This method can aid in identifying patients at high risk for CAD, independent of standard LDL-C measurements.